Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAI Floxuridine/Dex + IV Irinotecan for Colorectal Liver Metastases
NCT00003753Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Sep 1998
- Primary completion
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in colorectal cancer (CRC), sponsored by Memorial Sloan Kettering Cancer Center. Started Sep 1998; status: completed.
02
Drugs
irinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00003753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003753.